Quick Listen: Scrip’s Five Must-Know Things

In this week's episode: Marks on Trump’s threat to FDA; Amgen’s Phase II MariTide data lack clarity; Roche’s Poseida buyout; Roche’s CMO on his biotech lessons; and what Trump 2.0 might mean for India.

Scrip Five Must Know Things
weekly audio roundup of selected content from Scrip's global team

More from Podcasts

More from Business